BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32384736)

  • 1.
    Felix I; Lomada SK; Barth H; Wieland T
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.
    Khan I; Gril B; Steeg PS
    Cancer Res; 2019 Sep; 79(18):4689-4702. PubMed ID: 31311812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis suppressor NM23 limits oxidative stress in mammals by preventing activation of stress-activated protein kinases/JNKs through its nucleoside diphosphate kinase activity.
    Peuchant E; Bats ML; Moranvillier I; Lepoivre M; Guitton J; Wendum D; Lacombe ML; Moreau-Gaudry F; Boissan M; Dabernat S
    FASEB J; 2017 Apr; 31(4):1531-1546. PubMed ID: 28077425
    [No Abstract]   [Full Text] [Related]  

  • 4. Small molecule activator of Nm23/NDPK as an inhibitor of metastasis.
    Lee JJ; Kim HS; Lee JS; Park J; Shin SC; Song S; Lee E; Choi JE; Suh JW; Lee H; Kim EE; Seo EK; Shin DH; Lee HY; Lee HY; Lee KJ
    Sci Rep; 2018 Jul; 8(1):10909. PubMed ID: 30026594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of metastasis suppressor NME1 by a key metabolic cofactor coenzyme A.
    Yu BYK; Tossounian MA; Hristov SD; Lawrence R; Arora P; Tsuchiya Y; Peak-Chew SY; Filonenko V; Oxenford S; Angell R; Gouge J; Skehel M; Gout I
    Redox Biol; 2021 Aug; 44():101978. PubMed ID: 33903070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity.
    Zhang Q; McCorkle JR; Novak M; Yang M; Kaetzel DM
    Int J Cancer; 2011 Jan; 128(1):40-50. PubMed ID: 20209495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer.
    Duan S; Nordmeier S; Byrnes AE; Buxton ILO
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis.
    Mátyási B; Farkas Z; Kopper L; Sebestyén A; Boissan M; Mehta A; Takács-Vellai K
    Pathol Oncol Res; 2020 Jan; 26(1):49-61. PubMed ID: 31993913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma.
    Almgren MA; Henriksson KC; Fujimoto J; Chang CL
    Mol Cancer Res; 2004 Jul; 2(7):387-94. PubMed ID: 15280446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma.
    McCorkle JR; Leonard MK; Kraner SD; Blalock EM; Ma D; Zimmer SG; Kaetzel DM
    Cancer Genomics Proteomics; 2014; 11(4):175-94. PubMed ID: 25048347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.
    Tan CY; Chang CL
    Lab Invest; 2018 Feb; 98(2):219-227. PubMed ID: 28991262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of NME1/NDPK A null mouse liver: evidence for a post-translational regulation of annexin IV and EF-1Bα.
    Bruneel A; Wendum D; Labas V; Mulner-Lorillon O; Vinh J; Bosselut N; Ballot E; Baudin B; Housset C; Dabernat S; Lacombe ML; Boissan M
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):407-19. PubMed ID: 21541759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems.
    Khan I; Gril B; Hoshino A; Yang HH; Lee MP; Difilippantonio S; Lyden DC; Steeg PS
    Clin Exp Metastasis; 2022 Oct; 39(5):815-831. PubMed ID: 35939247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
    J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Nm23-H1 to suppress breast cancer metastasis via redox regulation.
    Kim B; Lee KJ
    Exp Mol Med; 2021 Mar; 53(3):346-357. PubMed ID: 33753879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial-Mesenchymal State in Cancer Cells.
    Huna A; Nawrocki-Raby B; Padilla-Benavides T; Gavard J; Coscoy S; Bernard D; Boissan M
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
    Ouatas T; Halverson D; Steeg PS
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of NM23 (NME) metastasis suppressor histidine phosphorylation to its nucleoside diphosphate kinase, histidine protein kinase and motility suppression activities.
    Khan I; Steeg PS
    Oncotarget; 2018 Feb; 9(12):10185-10202. PubMed ID: 29535799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
    Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
    Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance.
    Lodillinsky C; Fuhrmann L; Irondelle M; Pylypenko O; Li XY; Bonsang-Kitzis H; Reyal F; Vacher S; Calmel C; De Wever O; Bièche I; Lacombe ML; Eiján AM; Houdusse A; Vincent-Salomon A; Weiss SJ; Chavrier P; Boissan M
    Oncogene; 2021 Jun; 40(23):4019-4032. PubMed ID: 34012098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.